Cargando…
Comparing COVID-19-related Morbidity and Mortality Between Patients With and Without Substance Use Disorders: A Retrospective Cohort Study
OBJECTIVES: People with substance use disorders (SUD) are suggested to have higher risk of hospitalization, intubation, or death from coronavirus disease 2019 (COVID-19), although data are mixed. Little is known about other COVID-19-related complications in this group. We compared morbidity and mort...
Autores principales: | McLaughlin, Angela, Burns, Rebecca, Ryan, Morgan, Abbasi, Wafaa, Harvey, Leah, Hicks, Jacqueline, Sinha, Pranay, Assoumou, Sabrina A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034287/ https://www.ncbi.nlm.nih.gov/pubmed/36968974 http://dx.doi.org/10.1177/11782218231160014 |
Ejemplares similares
-
333. Comparing COVID-19-related Morbidity and Mortality between Patients with and without Substance Use Disorder: A Retrospective Cohort Study
por: McLaughlin, Angela, et al.
Publicado: (2021) -
Laboratory test trends within 72 hours of hospital admission associated with death among COVID-19 patients
por: Zambrano, Sarah, et al.
Publicado: (2022) -
Factors associated with inpatient complications among patients with obesity and COVID‐19 at an urban safety‐net hospital: A retrospective cohort study
por: Ryan, Tyler J., et al.
Publicado: (2022) -
Morbidity and mortality in schizophrenia with comorbid substance use disorders
por: Lähteenvuo, Markku, et al.
Publicado: (2021) -
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
por: Sinha, Pranay, et al.
Publicado: (2020)